Border Disease

Border disease is a contagious viral disease of sheep and goats caused by border disease virus (BDV), a pestivirus closely related to bovine viral diarrhea virus (BVDV) and classical swine fever virus. The disease was first recognized in the border region between England and Wales in the 1950s, giving it its distinctive name. Border disease primarily affects reproduction, causing abortion, stillbirth, and the birth of weak, malformed lambs, though it can also cause acute illness in adult sheep. The characteristic presentation in affected lambs includes abnormal fleece, tremors, and poor viability, leading to the alternative names hairy shaker disease and fuzzy lamb syndrome.

Border disease occurs worldwide wherever sheep are raised, with seroprevalence studies indicating widespread exposure in most sheep-producing regions. The virus circulates within sheep populations primarily through horizontal transmission via direct contact with infected animals and their secretions, as well as vertical transmission from infected ewes to their fetuses during pregnancy. Persistently infected animals, which become infected in utero during early gestation and remain viremic for life, serve as the primary reservoir for maintaining the virus within flocks. Goats are also susceptible to border disease virus infection and can develop similar clinical syndromes.

The economic impact of border disease stems primarily from reproductive losses including reduced conception rates, increased embryonic and fetal mortality, abortions, stillbirths, and the birth of non-viable lambs. Flocks experiencing their first exposure to border disease virus can suffer devastating lambing losses, with up to 50 percent of pregnancies affected in severe outbreaks. Beyond direct reproductive losses, persistently infected animals that survive contribute to ongoing viral circulation and may show poor growth rates and increased susceptibility to other diseases. Trade implications can arise when persistently infected animals unknowingly enter breeding stock sales or new flocks.

Early detection of border disease and identification of persistently infected animals are essential for controlling the disease within affected flocks. While no specific antiviral treatment exists, understanding the epidemiology of border disease enables implementation of effective prevention and control strategies. Vaccination is available in some regions and provides valuable protection for breeding ewes. Testing and removal of persistently infected animals interrupts the viral reservoir and can eventually eliminate the virus from closed flocks. Producers and veterinarians must maintain awareness of this often-underdiagnosed disease to minimize its impact on sheep health and productivity.

Border disease virus (BDV) is the causative agent of border disease, classified within the Pestivirus genus of the Flaviviridae family. The virus is an enveloped, single-stranded RNA virus with significant genetic diversity among circulating strains. Multiple genotypes of BDV have been identified worldwide, and cross-reactivity exists between BDV and other pestiviruses including bovine viral diarrhea virus and classical swine fever virus. This antigenic relationship has implications for diagnostic testing and vaccine development. The virus is relatively fragile in the environment but can survive for limited periods in organic material and is readily transmitted through direct contact between animals.

Genetic and breed predisposition to border disease is not well established, as all sheep breeds appear susceptible to infection. However, the severity of clinical disease may vary depending on viral strain characteristics and the timing of infection relative to pregnancy. The immunocompetence of individual animals influences their response to infection, with stressed or immunosuppressed sheep potentially experiencing more severe acute disease. No specific breed resistance to border disease has been documented, though indigenous breeds in endemic areas may have developed some degree of tolerance through generations of exposure.

Environmental and management factors significantly influence border disease transmission and impact. Intensive management systems with high stocking densities facilitate direct contact transmission between animals. Communal grazing, shared handling facilities, and congregation at water or feeding points increase exposure opportunities. Introduction of new animals without appropriate testing and quarantine represents a major risk for introducing the virus to naive flocks. Seasonal lambing management creates opportunities for transmission when large numbers of susceptible animals are concentrated. Poor biosecurity between sheep and cattle or goat enterprises may facilitate cross-species pestivirus transmission.

Risk factors for border disease include flock serostatus, with naive flocks that have never been exposed to the virus at greatest risk for severe outbreaks. Ewes infected during early to mid-pregnancy are at highest risk of producing persistently infected lambs, as fetal immunocompetence develops during this period. Young ewes in their first pregnancy may be more likely to be seronegative and thus susceptible to infection. Contact with persistently infected animals, whether known or unknowingly present in the flock, drives ongoing transmission. Purchasing breeding stock from infected flocks or at sales without testing introduces infection to clean operations.

The pathophysiology of border disease depends critically on the timing of infection relative to pregnancy. Infection of ewes before breeding generally results in seroconversion without pregnancy losses, as the immune response clears the virus before conception. Infection during the first 60 to 80 days of gestation, when the fetal immune system is not yet competent, allows the virus to establish persistent infection in the developing lamb. The fetus becomes immunotolerant to the virus and remains viremic for life, continuously shedding virus and serving as a reservoir. Infection during mid to late gestation may cause fetal death and abortion, or may result in congenitally infected lambs born with immune responses to the virus. These transiently infected lambs can clear the virus but may have developmental abnormalities resulting from in utero infection.

Early warning signs of border disease in a flock often manifest during the lambing season when the consequences of infection during pregnancy become apparent. Producers may first notice increased numbers of barren ewes that were believed to be pregnant, indicating early embryonic or fetal loss. Higher than normal abortion rates, particularly during mid to late gestation, may signal border disease activity in the flock. Some ewes may deliver mummified fetuses or show evidence of prolonged gestation. Careful observation during lambing reveals weak lambs, increased stillbirths, and lambs with abnormal fleece or neurological signs that suggest congenital infection.

Common symptoms in lambs congenitally infected with border disease virus include the characteristic presentation that earned the disease its alternative names. Affected lambs are often born with abnormally hairy birth coats, having coarse, kempy fibers intermixed with normal wool, giving them a distinctive fuzzy appearance. Hypomyelination of the central nervous system causes rhythmic tremors that are most obvious when lambs are excited or stressed. The tremors typically affect the entire body but may be most prominent in the head and neck. Affected lambs are often smaller than normal at birth and show failure to thrive despite adequate milk intake. Some lambs have skeletal abnormalities including domed skulls, shortened limbs, or arthrogryposis.

Behavioral changes in affected lambs are closely related to neurological dysfunction from hypomyelination. Affected lambs may have difficulty standing and nursing immediately after birth due to weakness and incoordination. The tremors interfere with normal suckling behavior, as lambs cannot maintain steady contact with the teat. Lambs may appear bright and alert but have exaggerated startle responses to stimuli. As they grow, affected lambs remain smaller than their cohorts and may show persistent neurological deficits. Some lambs with severe brain lesions exhibit more pronounced behavioral abnormalities including apparent blindness or abnormal mentation.

Physical signs of border disease extend beyond the fleece and neurological abnormalities. Congenitally infected lambs often display poor body condition despite adequate nutrition, with reduced muscle mass and prominent skeletal features. Skin hyperpigmentation may be present, particularly in colored breeds. Some lambs have entropion or other ocular abnormalities. Reproductive tract abnormalities may be detected in persistently infected animals as they mature. Growth rates remain depressed throughout life in persistently infected survivors, and they never achieve normal adult body weights. Fleece quality remains permanently altered, with affected animals producing inferior wool throughout their lives.

Symptom progression varies depending on the severity of congenital damage and whether lambs are persistently or transiently infected. Mildly affected lambs may show gradual improvement in neurological signs as compensatory myelination occurs over the first few months of life, with tremors becoming less pronounced or resolving entirely. However, persistently infected animals remain viremic and continue to shed virus regardless of clinical improvement. Severely affected lambs typically fail to thrive and often die within the first few weeks of life from secondary complications including pneumonia and starvation. Persistently infected animals that survive to adulthood may appear relatively normal but remain important virus reservoirs.

Emergency symptoms requiring immediate intervention include lambs that are unable to stand or nurse after birth due to severe neurological dysfunction. Hypothermia develops rapidly in weak lambs that cannot follow their dams or compete for milk. Aspiration pneumonia may occur in lambs with severe incoordination that affects swallowing. Ewes showing signs of dystocia or complications during delivery of malformed lambs require immediate veterinary attention. Sudden increases in abortion rates or lamb mortality should trigger veterinary investigation and diagnostic testing. Acute disease in adult sheep, though less common, can present with fever, leukopenia, and diarrhea, and requires differentiation from other causes of acute illness.

Clinical examination provides initial diagnostic clues for border disease, particularly when characteristic lambs are identified during lambing season. Veterinary assessment of affected lambs includes evaluation of fleece quality, observation for tremors and neurological deficits, assessment of body condition, and examination for other congenital abnormalities. The presence of multiple affected lambs within a flock, particularly in maiden ewes or newly introduced animals, strengthens clinical suspicion. Physical examination of ewes may reveal evidence of recent abortion or reproductive losses. Historical information about flock management, animal introductions, and previous lambing performance provides important context for diagnosis.

Laboratory diagnostic testing is essential for confirming border disease and identifying persistently infected animals. Virus detection methods include reverse transcription polymerase chain reaction (RT-PCR) testing of blood samples, which can identify viral RNA in both acutely and persistently infected animals. Virus isolation from blood or tissue samples provides definitive evidence of active infection. Antigen-capture ELISA tests can detect viral antigen in blood or tissue samples and are useful for identifying persistently infected animals. Testing should be performed on multiple animals to establish flock infection status, with particular attention to animals showing clinical signs suggestive of congenital infection.

Serological testing using ELISA methods detects antibodies to border disease virus and provides information about flock exposure history. Seronegative animals have not been exposed to the virus and remain susceptible to infection. Seropositive animals have been exposed and developed immune responses, providing some protection against reinfection. Importantly, persistently infected animals are typically seronegative despite carrying and shedding the virus, as they are immunotolerant and do not mount antibody responses to the virus they recognize as self. This characteristic makes serological testing useful for distinguishing persistently infected from recovered animals. Paired serology demonstrating seroconversion confirms recent infection.

Differential diagnosis for border disease includes other causes of abortion, weak lambs, and neurological disease in sheep. Toxoplasmosis causes abortion and congenital abnormalities that can mimic border disease. Enzootic abortion (chlamydiosis) produces late-term abortions. Campylobacter infection causes abortion and weak lambs. Schmallenberg virus infection produces congenital neurological disease and skeletal abnormalities similar to border disease. Copper deficiency causes swayback, characterized by hindlimb incoordination that differs from the generalized tremors of border disease. Other causes of abortion and neonatal mortality should be considered in the diagnostic workup.

Herd-level diagnostic approaches help establish the extent of border disease infection within a flock and guide control strategies. Screening all breeding-age animals using antigen detection tests identifies persistently infected individuals for removal. Bulk milk testing in dairy sheep operations can provide preliminary evidence of viral circulation. Systematic serological surveys characterize flock immunity and identify susceptible subpopulations. Necropsy examination of aborted fetuses, stillborn lambs, and lambs that die shortly after birth provides diagnostic samples and reveals characteristic pathological changes including thymic atrophy, hypomyelination of brain and spinal cord, and abnormal skin and wool follicle development. Combining individual animal testing with flock-level surveillance enables comprehensive disease characterization and informs control recommendations.

Emergency treatment for lambs severely affected by congenital border disease focuses on supportive care and managing immediate survival needs. Weak lambs require warming and drying immediately after birth, as hypothermia develops rapidly in neurologically compromised neonates. Assistance with colostrum feeding is often necessary, as affected lambs may be unable to nurse effectively due to tremors and weakness. Stomach tube feeding provides an alternative route for delivering colostrum and milk to lambs that cannot suckle. Protection from environmental stress including cold, wet conditions, and aggressive flockmates improves survival chances for affected lambs.

Medical management options for border disease are extremely limited, as no specific antiviral treatments exist for pestivirus infections. Symptomatic treatment addresses secondary complications and maintains comfort in affected animals. Anti-inflammatory medications may provide supportive benefit for lambs with severe neurological dysfunction but do not address the underlying viral infection. Antibiotic treatment is appropriate when secondary bacterial infections complicate the disease picture, particularly pneumonia in weak lambs with compromised respiratory defenses. All treatments in food-producing animals must comply with withdrawal time requirements to ensure food safety.

Surgical intervention is not applicable for the viral infection itself but may address specific complications. Entropion, which occurs at increased frequency in some affected lambs, requires surgical or mechanical correction to prevent corneal damage. Other congenital abnormalities may occasionally warrant surgical attention depending on their nature and severity. However, the fundamental issue of viral infection cannot be addressed surgically, and treatment decisions must consider the prognosis for affected individuals.

Supportive care for border disease-affected lambs emphasizes meeting basic needs that the animals cannot adequately provide for themselves. Ensuring adequate nutrition through assisted feeding supports growth and development as much as possible given the congenital damage. Housing affected lambs in protected environments reduces stress and energy demands. Grouping similarly affected lambs together prevents competition with stronger flockmates. Monitoring for secondary complications allows early intervention when problems develop. Gentle handling minimizes stress that exacerbates neurological signs. Providing soft bedding and appropriate shelter addresses comfort needs of compromised animals.

Herd treatment protocols during border disease outbreaks focus on minimizing transmission and protecting susceptible animals rather than treating infected individuals. Identifying and removing persistently infected animals eliminates the primary viral reservoir. Separating pregnant ewes from known or suspected infected animals reduces transmission risk during the critical gestational period. Implementing biosecurity measures prevents further viral introduction. Vaccination of susceptible breeding stock, where vaccines are available, provides protection for future pregnancies. Enhanced monitoring during lambing identifies affected offspring for appropriate management decisions.

Treatment decisions regarding individual border disease-affected animals involve weighing welfare, economic, and practical considerations. Mildly affected lambs with good vigor and ability to nurse may be worth rearing if they are not persistently infected, as neurological signs often improve with age. However, persistently infected animals should not be retained for breeding regardless of clinical status, as they continuously shed virus and perpetuate infection in the flock. Severely affected lambs with poor prognosis may be candidates for humane euthanasia on welfare grounds. The economic value of affected animals rarely justifies intensive treatment efforts, and culling persistently infected animals is essential for disease control regardless of their apparent clinical condition.

Recovery timeline for lambs congenitally infected with border disease depends on infection category and severity of developmental damage. Transiently infected lambs that mounted fetal immune responses to the virus may show gradual improvement over several weeks to months as compensatory myelination occurs. Tremors typically become less pronounced during the first few months of life and may resolve entirely in mildly affected animals. However, growth rates often remain below normal even in lambs that show neurological improvement. Persistently infected lambs do not clear the virus regardless of clinical status and remain infectious throughout their lives, which are often shortened by secondary complications.

Post-treatment care and monitoring for surviving border disease lambs involves ongoing assessment of growth, development, and general health. Regular weighing documents growth patterns and identifies lambs failing to thrive despite adequate nutrition. Continued observation for neurological signs tracks improvement or persistence of deficits. Monitoring for respiratory infections and other secondary complications allows early treatment intervention. Assessment of fleece quality documents the permanent wool abnormalities that affect fiber value. As lambs mature, evaluation for reproductive function becomes relevant if retention for breeding is considered, though persistently infected animals must never be used for breeding.

Prognosis for border disease varies dramatically based on infection status and initial disease severity. Transiently infected lambs with mild congenital changes may recover to near-normal function and productivity, though permanent effects on growth and fleece quality may persist. Severely affected lambs with profound neurological damage or major developmental abnormalities have poor prognosis and often die within weeks of birth. Persistently infected animals have guarded long-term prognosis regardless of apparent clinical recovery, as they remain immunocompromised and susceptible to secondary infections throughout their shortened lives. These animals also represent ongoing biosecurity risks to other sheep and should be culled.

Return to production considerations highlight the permanent consequences of border disease infection. Recovered transiently infected sheep may achieve reasonable productivity but typically remain below genetic potential due to developmental impacts. Fleece quality abnormalities persist throughout life, reducing wool value at every shearing. Growth rates often remain depressed, affecting market weight and timing. The critical consideration is whether animals are persistently or transiently infected, as this determines their suitability for retention in the flock. Persistently infected animals must never be returned to breeding populations or sold to other producers, as they perpetuate disease wherever they go. Testing to confirm infection status is essential before making retention decisions for any animal affected by border disease.

Vaccination protocols provide effective prevention for border disease in regions where vaccines are available. Inactivated vaccines containing border disease virus antigens stimulate protective immunity in breeding ewes before pregnancy. Vaccination is typically administered to ewes prior to mating, with timing allowing adequate antibody development before conception. Booster vaccinations may be required according to manufacturer recommendations and veterinary advice. In some regions, polyvalent vaccines protecting against multiple pestiviruses including BVD and border disease are available. Vaccination programs should target all breeding-age females, with particular attention to replacement animals entering the breeding flock.

Biosecurity measures are essential for preventing border disease introduction to naive flocks. Maintaining closed flocks without animal introductions eliminates the primary source of viral entry. When purchasing animals is necessary, source from flocks with documented negative testing status and quarantine new arrivals with testing before joining the main flock. Avoid contact with neighboring flocks through adequate fencing and avoiding shared equipment or facilities. Preventing contact between sheep and cattle reduces risk of cross-species pestivirus transmission. Implement strict protocols for show and sale animals, with testing before reintroduction to home flocks. Require negative testing documentation for all animal purchases and introductions.

Nutritional prevention for border disease focuses on maintaining optimal immune function and reducing stress that may increase susceptibility to infection. Ensuring adequate trace mineral nutrition, particularly copper, selenium, and zinc, supports immune competence in breeding ewes. Providing appropriate energy and protein nutrition during late pregnancy supports fetal development and lamb vigor. Avoiding nutritional stress that might compromise immune responses helps ewes resist infection or respond more effectively when exposed. Good body condition entering the breeding season and maintained throughout pregnancy provides metabolic reserves for immune function.

Management practices that reduce border disease risk include systematic testing and removal of persistently infected animals from the flock. Regular serological monitoring identifies new infections and guides management responses. Separating age groups reduces transmission from older carrier animals to young stock. Managing lambing to reduce environmental contamination and direct contact between ewes minimizes transmission during the period when pregnant ewes are most vulnerable. Strict culling of all identified persistently infected animals, regardless of clinical appearance, eliminates the viral reservoir. Recording and tracking reproductive performance helps identify patterns suggestive of border disease activity.

Quarantine and testing protocols form the cornerstone of border disease prevention when introducing new animals. All purchased animals should be isolated from the main flock for a minimum of 30 days, during which testing for border disease virus can be completed. Testing should include both antigen detection to identify persistently infected animals and serology to establish exposure history. Animals testing positive for viral antigen should never be introduced to the flock. Seropositive animals have been exposed but pose less risk than actively infected individuals. Repeated testing at intervals during quarantine increases confidence in negative status. Working with veterinarians to develop appropriate testing and quarantine protocols ensures effective protection while remaining practically feasible.

Daily management and monitoring for flocks managing border disease requires attention to reproductive performance indicators and lamb health. Recording conception rates, abortion rates, and neonatal mortality provides data for detecting disease activity. Careful observation during lambing identifies affected lambs for appropriate management decisions. Monitoring growth rates in young stock reveals persistently infected animals that fail to thrive. Regular assessment of flock health status helps detect changes that might indicate viral circulation. Maintaining accurate individual animal identification enables tracking of potentially infected animals and their offspring.

Housing and environmental management influence border disease transmission dynamics within flocks. Avoiding overcrowding reduces direct contact opportunities and environmental contamination. Providing adequate lambing space allows ewes and lambs to be managed in small groups, reducing transmission during the vulnerable neonatal period. Proper ventilation in housing reduces aerosol transmission and decreases respiratory disease that may complicate border disease. Maintaining clean, dry bedding minimizes environmental viral persistence. Separating pregnant ewes from young stock and animals of unknown status reduces transmission to susceptible individuals during critical gestational periods.

Herd health programs addressing border disease integrate testing, vaccination, and management into comprehensive strategies. Working with veterinarians to establish baseline flock status through serological surveys informs management decisions. Implementing annual testing programs for breeding stock identifies persistently infected animals for removal. Coordinating vaccination timing with breeding schedules ensures protective immunity during pregnancy. Including border disease in diagnostic workups for reproductive failures ensures the disease is not overlooked. Integrating border disease management with broader flock health programs improves efficiency and producer compliance.

Record keeping and monitoring systems support effective border disease management over time. Maintaining individual animal testing records documents infection status and enables tracing of potentially exposed animals. Recording reproductive performance metrics identifies changes that may signal disease activity. Tracking lamb growth rates and mortality reveals persistently infected individuals. Documenting vaccination status ensures appropriate protection for all breeding animals. Recording animal movements and introductions supports biosecurity programs and enables tracing if disease is detected. Electronic record systems facilitate analysis and reporting while reducing administrative burden.

Economic considerations for border disease management include the costs of testing, vaccination, and culling weighed against losses from uncontrolled disease. Regular testing programs require ongoing investment but enable identification and removal of persistently infected animals that would otherwise perpetuate losses. Vaccination costs are modest compared to the reproductive losses that can occur during outbreaks in naive flocks. Culling persistently infected animals involves immediate economic loss but eliminates the source of ongoing viral transmission. Considering the long-term economics of disease control versus the cumulative costs of ongoing reproductive losses helps justify investment in prevention. Working with veterinarians and animal health economists can help develop cost-effective management strategies appropriate for individual operations.

High-risk breeds for border disease are not clearly defined, as all sheep breeds appear susceptible to infection. However, the consequences of infection may vary between breeds and production systems. Fine-wool breeds that depend on wool quality for value may suffer greater economic impact from the permanent fleece abnormalities in congenitally affected animals. Prolific breeds with multiple lambing may experience greater absolute numbers of affected offspring during outbreaks. Breeds with limited genetic diversity may be more vulnerable to severe disease if genetic factors influence susceptibility. Indigenous breeds in regions where border disease has been endemic for many generations may have developed some degree of tolerance, though this has not been clearly documented.

Production type considerations influence border disease impact and management priorities. Dairy sheep operations face particular challenges, as persistently infected animals may enter milking groups and transmit virus to susceptible pregnant ewes. Meat production systems must consider the growth rate penalties affecting persistently infected animals that survive. Breeding stock operations bear responsibility for preventing sale of persistently infected animals that could introduce disease to other flocks. Extensive range operations face challenges in implementing testing programs due to logistical constraints. Organic operations may have limited vaccination options depending on certification standards.

Genetic selection and testing offer potential tools for border disease management within breeding programs. While no specific genetic markers for border disease resistance have been identified in sheep, selection for general disease resistance and immune competence may provide some benefit. Testing breeding stock before sale ensures that persistently infected animals are not distributed to other operations. Sire testing programs prevent use of persistently infected rams that could transmit virus venereally and produce large numbers of exposed lambs. Dam testing identifies persistently infected ewes that would produce persistently infected lambs. Incorporating disease testing into breeding program protocols protects both individual operations and the broader sheep industry from border disease spread.

Commonly co-occurring conditions with border disease reflect both the immunocompromised status of persistently infected animals and secondary complications of congenital damage. Respiratory infections including pneumonia occur with increased frequency in persistently infected lambs due to impaired immune responses. Enteric diseases may be more severe in immunocompromised animals. Secondary bacterial infections can complicate the neurological compromise seen in affected lambs. Poor body condition and failure to thrive make affected animals more susceptible to a wide range of opportunistic infections. Parasitic burdens may be greater in persistently infected animals due to reduced ability to mount effective immune responses.

Conditions with similar symptoms that must be differentiated from border disease include other causes of abortion, congenital abnormalities, and neurological disease in lambs. Toxoplasmosis causes abortion and occasionally congenital abnormalities that may resemble border disease. Schmallenberg virus infection produces congenital neurological disease and skeletal malformations similar to those seen with border disease. Copper deficiency causes swayback with hindlimb incoordination, which differs from the generalized tremors of border disease but may cause diagnostic confusion. Cache Valley virus and other teratogenic agents can produce congenital abnormalities. Bovine viral diarrhea virus cross-infection from cattle can produce similar clinical syndromes in sheep and may be detected by some BDV diagnostic tests.

Complications and sequelae of border disease extend throughout the lives of surviving affected animals. Persistent immunocompromise in persistently infected animals leads to increased susceptibility to various infectious diseases. Growth rate depression affects market weight and timing, reducing economic returns. Permanent wool abnormalities decrease fleece value throughout the animal's productive life. Reproductive failure may occur in persistently infected animals that survive to breeding age, though such animals should be culled before breeding. The primary long-term complication of border disease at the flock level is ongoing viral circulation if persistently infected animals remain in the population, perpetuating reproductive losses in subsequent years.